Search
for
Sort by
Research 91–120 of 678
- The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study
- Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer
- Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention
- Prostate cancer update: 2007
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Long-Term Experience With 5-alpha-Reductase Inhibitors.
- Inhibitory effects of TripTripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats
- Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia
- Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
- Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States
- Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
- Evaluation of healthcare for transgender veterans
- Is there a relationship between androgenic alopecia and benign prostatic hyperplasia?
- Doxazosin and finasteride alone or in combination: the PREDICT study
- Effect of finasteride on prostate-specific antigen
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial
- Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia
- Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?
- Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia
- Finasteride in Androgenic Alopecia
- Serum Prostate Specific Antigen level in Women with Polycystic Ovary Syndrome
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- 복분자 미숙과 추출물이 전립선암 세포주와 전립선비대 백서모델에 미치는 영향
- Trichoscopy in alopecias
- Prostate-specific antigen as a diagnostic marker in female hyperandrogenism
- Editorial Comment